EP1943350A4 - Latent procytotoxins and uses thereof - Google Patents
Latent procytotoxins and uses thereofInfo
- Publication number
- EP1943350A4 EP1943350A4 EP06825387A EP06825387A EP1943350A4 EP 1943350 A4 EP1943350 A4 EP 1943350A4 EP 06825387 A EP06825387 A EP 06825387A EP 06825387 A EP06825387 A EP 06825387A EP 1943350 A4 EP1943350 A4 EP 1943350A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- procytotoxins
- latent
- latent procytotoxins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72351105P | 2005-10-04 | 2005-10-04 | |
PCT/US2006/038584 WO2007044321A2 (en) | 2005-10-04 | 2006-09-29 | Latent procytotoxins and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1943350A2 EP1943350A2 (en) | 2008-07-16 |
EP1943350A4 true EP1943350A4 (en) | 2009-06-17 |
Family
ID=37943314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06825387A Withdrawn EP1943350A4 (en) | 2005-10-04 | 2006-09-29 | Latent procytotoxins and uses thereof |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1943350A4 (en) |
JP (1) | JP2009510166A (en) |
AU (1) | AU2006302587A1 (en) |
CA (1) | CA2624802A1 (en) |
WO (1) | WO2007044321A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150174265A1 (en) * | 2012-06-26 | 2015-06-25 | Massachusetts Institute Of Technology | Reversible masking of pore-forming proteins for macromolecular delivery |
CN103275911B (en) * | 2013-01-02 | 2015-11-25 | 温州医学院 | A kind of intestinal bacteria containing pET-28a (+)-protein400 recombinant plasmid and preparation method thereof |
JP6544806B2 (en) * | 2013-06-27 | 2019-07-17 | ラトガース,ザ ステート ユニバーシティ オブ ニュー ジャージー | Treatment and diagnosis of eye disease |
CN106632633B (en) * | 2016-11-24 | 2020-03-20 | 浙江海洋大学 | Abelmoschus moschatus antitumor oligopeptide and application thereof |
EP4041277A4 (en) * | 2019-10-11 | 2024-01-24 | Linnane Pharma AB | Vibrio cholerae protein for use against cancer |
CN112724258A (en) * | 2019-10-29 | 2021-04-30 | 深圳市第二人民医院 | Composite polypeptide molecule for targeted killing of cancer cells and preparation method thereof |
EP4182334A4 (en) * | 2020-07-17 | 2024-10-16 | Univ Western Australia | Compositions and methods for the treatment of cancer |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020045736A1 (en) * | 2001-05-09 | 2002-04-18 | Xianxhang Yu | Lytic peptide prodrugs |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0100551D0 (en) * | 2001-01-09 | 2001-02-21 | Queen Mary & Westfield College | Protein |
-
2006
- 2006-09-29 JP JP2008534617A patent/JP2009510166A/en active Pending
- 2006-09-29 CA CA002624802A patent/CA2624802A1/en not_active Abandoned
- 2006-09-29 AU AU2006302587A patent/AU2006302587A1/en not_active Abandoned
- 2006-09-29 WO PCT/US2006/038584 patent/WO2007044321A2/en active Application Filing
- 2006-09-29 EP EP06825387A patent/EP1943350A4/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020045736A1 (en) * | 2001-05-09 | 2002-04-18 | Xianxhang Yu | Lytic peptide prodrugs |
Also Published As
Publication number | Publication date |
---|---|
WO2007044321A2 (en) | 2007-04-19 |
CA2624802A1 (en) | 2007-04-19 |
AU2006302587A1 (en) | 2007-04-19 |
WO2007044321A3 (en) | 2007-07-05 |
EP1943350A2 (en) | 2008-07-16 |
JP2009510166A (en) | 2009-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1802588A4 (en) | Substituted amino-pyrimidones and uses thereof | |
IL222922A (en) | Anti-neuropilin-1 antibodies and uses thereof | |
HK1119441A1 (en) | Toner | |
AP2008004471A0 (en) | Anti-Alpha2 Intergin antibodies and their uses | |
EP1944655A4 (en) | Toner | |
IL184024A0 (en) | Irta-5 antibodies and their uses | |
IL189609A0 (en) | 4-substituted pyrrolidin-2-ones and their use | |
EP1962142A4 (en) | Toner | |
GB0512940D0 (en) | Compounds and their use | |
IL179497A0 (en) | Carboranylporphyrins and uses thereof | |
EP1893569A4 (en) | Sulfonamide compounds and uses thereof | |
IL189252A0 (en) | Dihydroxyanthraquinones and their use | |
HK1133552A1 (en) | Carboranylporphyrins and uses thereof | |
EP1912921A4 (en) | Tetraazaporphyrin-based compounds and their uses | |
EP1921066A4 (en) | Pyridylphenol compound and use thereof | |
IL185223A0 (en) | Compounds and uses thereof | |
IL180365A0 (en) | Carboranylporphyrins and uses thereof | |
EP1943350A4 (en) | Latent procytotoxins and uses thereof | |
GB0520743D0 (en) | Compounds and their use | |
EP1887432A4 (en) | Toner and toner binder | |
GB0502979D0 (en) | Biomarkers and uses thereof | |
GB0520935D0 (en) | Integrated processor-template-system and project | |
GB0502978D0 (en) | Biomarkers and uses thereof | |
GB0517239D0 (en) | Geogrotren-mk1-system and project | |
GB0517240D0 (en) | Chronorotron mk1-system and project |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080408 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090520 |
|
17Q | First examination report despatched |
Effective date: 20090907 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100318 |